Lopez Acevedo, M., Poniewierski, M., Hanna, R., Laskey, R., Lyman, G., Gehrig, P., … Havrilesky, L. (2012). Impact of platelet count in women with advanced ovarian cancer receiving adjuvant multi-agent systemic chemotherapy. In Gynecologic Oncology (Vol. 125, pp. S68–S69). Elsevier BV. https://doi.org/10.1016/j.ygyno.2011.12.163

Lopez Acevedo, M., M. Poniewierski, R. Hanna, R. Laskey, G. Lyman, P. Gehrig, A. Alvarez-Secord, and L. Havrilesky. “Impact of platelet count in women with advanced ovarian cancer receiving adjuvant multi-agent systemic chemotherapy.” In Gynecologic Oncology, 125:S68–69. Elsevier BV, 2012. https://doi.org/10.1016/j.ygyno.2011.12.163.

Lopez Acevedo M, Poniewierski M, Hanna R, Laskey R, Lyman G, Gehrig P, et al. Impact of platelet count in women with advanced ovarian cancer receiving adjuvant multi-agent systemic chemotherapy. In: Gynecologic Oncology. Elsevier BV; 2012. p. S68–9.

Lopez Acevedo, M., et al. “Impact of platelet count in women with advanced ovarian cancer receiving adjuvant multi-agent systemic chemotherapy.” Gynecologic Oncology, vol. 125, Elsevier BV, 2012, pp. S68–69. Crossref, doi:10.1016/j.ygyno.2011.12.163.

Lopez Acevedo M, Poniewierski M, Hanna R, Laskey R, Lyman G, Gehrig P, Alvarez-Secord A, Havrilesky L. Impact of platelet count in women with advanced ovarian cancer receiving adjuvant multi-agent systemic chemotherapy. Gynecologic Oncology. Elsevier BV; 2012. p. S68–S69.